KADEPSI Trademark

Trademark Overview

On Wednesday, April 24, 2019, a trademark application was filed for KADEPSI with the United States Patent and Trademark Office. The USPTO has given the KADEPSI trademark a serial number of 88399930. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 14, 2022. This trademark is owned by Glaxo Group Limited. The KADEPSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kadepsi

General Information

Serial Number88399930
Word MarkKADEPSI
Filing DateWednesday, April 24, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, November 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 25, 2022SOU EXTENSION 5 GRANTED
Tuesday, March 29, 2022SOU EXTENSION 5 FILED
Thursday, August 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 29, 2022TEAS EXTENSION RECEIVED
Saturday, October 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 8, 2021SOU EXTENSION 4 GRANTED
Tuesday, September 28, 2021SOU EXTENSION 4 FILED
Monday, October 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 28, 2021TEAS EXTENSION RECEIVED
Thursday, February 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 23, 2021SOU EXTENSION 3 GRANTED
Tuesday, February 23, 2021SOU EXTENSION 3 FILED
Tuesday, February 23, 2021TEAS EXTENSION RECEIVED
Thursday, September 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 8, 2020SOU EXTENSION 2 GRANTED
Tuesday, September 8, 2020SOU EXTENSION 2 FILED
Tuesday, September 8, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 7, 2020SOU EXTENSION 1 GRANTED
Friday, February 7, 2020SOU EXTENSION 1 FILED
Friday, February 7, 2020TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 4, 2019ASSIGNED TO EXAMINER
Friday, May 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 27, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

kadepsi pharmaceutical substances treatment preparations diseases disorders respiratory oncological genitourinary neurological